500
0
0
Skip to Content
Lung Cancer Europe | Advocacy and Access for Lung Cancer in Europe
🔍
Overview
Our Board
Brand hub
Contact
11th Report
11th Report Press Release
10th Report
English
Lung Cancer Europe | Advocacy and Access for Lung Cancer in Europe
🔍
Overview
Our Board
Brand hub
Contact
11th Report
11th Report Press Release
10th Report
English
🔍
Folder: Who We Are
Back
Overview
Our Board
Brand hub
Contact
Folder: Annual Reports
Back
11th Report
11th Report Press Release
10th Report
English
Back
No results found
Get Checked 2026
Advocacy, Diagnosis, News Web Team 01/08/2026 Advocacy, Diagnosis, News Web Team 01/08/2026

Get Checked 2026

Read More
How Doctors Find and Remove Tiny Lung Nodules
Treatment, Diagnosis, News Web Team 14/07/2026 Treatment, Diagnosis, News Web Team 14/07/2026

How Doctors Find and Remove Tiny Lung Nodules

Read More
A lung cancer mutation that has resisted treatment for decades may finally have a drug
News, Treatment, Access, Diagnosis Web Team 20/04/2026 News, Treatment, Access, Diagnosis Web Team 20/04/2026

A lung cancer mutation that has resisted treatment for decades may finally have a drug

Read More
Faster biomarker testing for lung cancer: our FAST-NGS pilot reaches Greece
News, LuCE News, Access, Diagnosis, Treatment Web Team 18/04/2026 News, LuCE News, Access, Diagnosis, Treatment Web Team 18/04/2026

Faster biomarker testing for lung cancer: our FAST-NGS pilot reaches Greece

Read More
AI That Sees Lung Scans the Way a Radiologist Does
News, Diagnosis, Advocacy Web Team 14/04/2026 News, Diagnosis, Advocacy Web Team 14/04/2026

AI That Sees Lung Scans the Way a Radiologist Does

Read More
Why biomarker testing should be routine in all NSCLC
Treatment, Diagnosis, LuCE News, News Web Team 02/04/2026 Treatment, Diagnosis, LuCE News, News Web Team 02/04/2026

Why biomarker testing should be routine in all NSCLC

Read More
Exercise after lung cancer diagnosis linked to better outcomes
News, Supportive care, Diagnosis Web Team 15/03/2026 News, Supportive care, Diagnosis Web Team 15/03/2026

Exercise after lung cancer diagnosis linked to better outcomes

Read More

With Thanks to Our Supporters

Lung Cancer Europe is grateful to the partners who share our commitment to people affected by lung cancer. Their support helps us turn our mission into action across research, education and advocacy.

Accord Healthcare Amgen Bayer AstraZeneca BeOne Medicines BioNTech Blueprint Medicines Bristol Myers Squibb Boehringer Ingelheim Daiichi Sankyo Genmab Gilead Johnson & Johnson Lilly Merck Group MSD Novartis Novocure Pfizer PharmaCosmos PharmaMar Pierre Fabre Regeneron Roche Takeda Thermo Fisher

Connect with us on LinkedIn

Stay in the loop

You can subscribe to updates from Lung Cancer Europe by signing up to our monthly newsletter below. Our newsletter goes out on 1st of every month and we also send out news bulletins and updates.

By signing up, you agree to receive emails from Lung Cancer Europe. You can unsubscribe at any time. Read our Privacy Policy to learn how we handle your data.

PRIVACY POLICY

© Lung Cancer Europe 2026 | Designed by Laura Jones